Krahn M - Search Results

1

A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C.

Saeed YA, Phoon A, Bielecki JM, Mitsakakis N, Bremner KE, Abrahamyan L, Pechlivanoglou P, Feld JJ, Krahn M, Wong WWL. Saeed YA, et al. Among authors: krahn m. Value Health. 2020 Jan;23(1):127-137. doi: 10.1016/j.jval.2019.07.005. Epub 2019 Nov 28. Value Health. 2020. PMID: 31952667 Free article.

2

The ten-year rule revisited: accuracy of clinicians' estimates of life expectancy in patients with localized prostate cancer.

Krahn MD, Bremner KE, Asaria J, Alibhai SM, Nam R, Tomlinson G, Jewett MA, Warde P, Naglie G. Krahn MD, et al. Urology. 2002 Aug;60(2):258-63. doi: 10.1016/s0090-4295(02)01712-0. Urology. 2002. PMID: 12137823

3

Patient and community preferences for outcomes in prostate cancer: implications for clinical policy.

Krahn M, Ritvo P, Irvine J, Tomlinson G, Bremner KE, Bezjak A, Trachtenberg J, Naglie G. Krahn M, et al. Med Care. 2003 Jan;41(1):153-64. doi: 10.1097/00005650-200301000-00017. Med Care. 2003. PMID: 12544552

4

Health-state utilities and quality of life in hepatitis C patients.

Chong CA, Gulamhussein A, Heathcote EJ, Lilly L, Sherman M, Naglie G, Krahn M. Chong CA, et al. Among authors: krahn m. Am J Gastroenterol. 2003 Mar;98(3):630-8. doi: 10.1111/j.1572-0241.2003.07332.x. Am J Gastroenterol. 2003. PMID: 12650799

5

Indications for interferon/ribavirin therapy in hepatitis C patients: findings from a survey of Canadian hepatologists.

Wang P, Yi Q, Scully L, Heathcote J, Krahn M. Wang P, et al. Among authors: krahn m. Can J Gastroenterol. 2003 Mar;17(3):183-6. doi: 10.1155/2003/498120. Can J Gastroenterol. 2003. PMID: 12677268

6

A Canadian national survey of attitudes and knowledge regarding preventive vaccines.

Ritvo P, Irvine J, Klar N, Wilson K, Brown L, Bremner KE, Rinfret A, Remis R, Krahn MD. Ritvo P, et al. J Immune Based Ther Vaccines. 2003 Nov 5;1(1):3. doi: 10.1186/1476-8518-1-3. J Immune Based Ther Vaccines. 2003. PMID: 14613575 Free PMC article.

7

Economic analysis of a phase III clinical trial evaluating the addition of total androgen suppression to radiation versus radiation alone for locally advanced prostate cancer (Radiation Therapy Oncology Group protocol 86-10).

Konski A, Sherman E, Krahn M, Bremner K, Beck JR, Watkins-Bruner D, Pilepich M. Konski A, et al. Among authors: krahn m. Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):788-94. doi: 10.1016/j.ijrobp.2005.03.010. Int J Radiat Oncol Biol Phys. 2005. PMID: 16109464 Clinical Trial.

8

Predictors of antiviral therapy in a post-transfusion cohort of hepatitis C patients.

Witkos M, Yi QL, Heathcote J, Kapral MK, Krahn MD. Witkos M, et al. Among authors: krahn md. Can J Gastroenterol. 2006 Feb;20(2):107-11. doi: 10.1155/2006/638272. Can J Gastroenterol. 2006. PMID: 16482237 Free PMC article.

9

Responsiveness of disease-specific and generic utility instruments in prostate cancer patients.

Krahn M, Bremner KE, Tomlinson G, Ritvo P, Irvine J, Naglie G. Krahn M, et al. Qual Life Res. 2007 Apr;16(3):509-22. doi: 10.1007/s11136-006-9132-x. Epub 2006 Nov 8. Qual Life Res. 2007. PMID: 17091359

10

A review and meta-analysis of prostate cancer utilities.

Bremner KE, Chong CA, Tomlinson G, Alibhai SM, Krahn MD. Bremner KE, et al. Among authors: krahn md. Med Decis Making. 2007 May-Jun;27(3):288-98. doi: 10.1177/0272989X07300604. Epub 2007 May 14. Med Decis Making. 2007. PMID: 17502448 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

576 results

Search Page

Filters